Response Timeline for Prednisolone 30 mg Daily in Skin Lesions
You should expect to see initial response to prednisolone 30 mg per day within 5-7 days, with disease control defined as cessation of new lesion formation and onset of healing in existing lesions. 1
Expected Timeline Based on Condition Severity
For Pemphigus and Severe Autoimmune Blistering Disorders
- Initial response window: 5-7 days is the critical assessment point 1
- If no response is observed within this timeframe, the British Association of Dermatologists recommends increasing the dose by 50-100% increments 1
- Disease control is specifically defined as: no new lesions appearing AND the onset of healing in pre-existing lesions 1
- Treatment failure is formally defined as lack of disease control despite 3 weeks of therapy at 1.5 mg/kg per day (approximately 105 mg for a 70 kg patient) 1
For Moderate Inflammatory Dermatoses
- Response within 1-3 weeks is typical for conditions like bullous pemphigoid when using prednisolone 0.5 mg/kg per day (approximately 35 mg for a 70 kg patient) 1
- If no disease control is achieved within 1-3 weeks at this dose, guidelines recommend increasing to 0.75 mg/kg per day 1
For Severe Inflammatory Conditions (Acne Fulminans, Vasculitis)
- Resolution of systemic signs within 1 month with prednisolone 30 mg daily (given as 10-10-10 mg three times daily) 2
- >50% improvement in skin lesions within 1 month in 65% of patients 2
- For necrotizing skin lesions in vasculitis, eosinophilia may decrease rapidly, though severe tissue damage may persist 3
Critical Assessment Points
Week 1 (Days 5-7)
- This is your first decision point 1
- Look specifically for: cessation of new lesion formation and early signs of healing in existing lesions 1
- If no response, consider dose escalation rather than waiting longer 1
Week 2-3
- Secondary assessment window for moderate inflammatory conditions 1
- By this point, you should see clear improvement or consider the treatment inadequate 1
Week 4 (1 Month)
- Expected timepoint for substantial improvement in severe inflammatory conditions 2
- Systemic symptoms (fever, arthralgia) should have resolved by this point if present 2
Important Clinical Pitfalls
Dose Considerations
- 30 mg daily is considered a low-moderate dose for many severe dermatologic conditions 1
- For a 70 kg patient, this represents approximately 0.43 mg/kg, which is at the lower end of recommended dosing for severe disease 1
- The British Association of Dermatologists notes that standard practice for severe pemphigus typically starts at 1-2 mg/kg (70-140 mg for a 70 kg patient) 1
Avoiding Treatment Delays
- Do not wait beyond 5-7 days without response before reassessing 1
- Delayed dose escalation may prolong disease activity and increase cumulative steroid exposure 1
- Consider that 30 mg may be insufficient as initial therapy for extensive or severe disease 1